1. Home
  2. MGYR vs RFL Comparison

MGYR vs RFL Comparison

Compare MGYR & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Magyar Bancorp Inc.

MGYR

Magyar Bancorp Inc.

HOLD

Current Price

$19.39

Market Cap

123.3M

Sector

Finance

ML Signal

HOLD

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$2.05

Market Cap

133.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGYR
RFL
Founded
1922
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Real Estate
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
123.3M
133.1M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
MGYR
RFL
Price
$19.39
$2.05
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.5K
110.6K
Earning Date
04-23-2026
06-10-2026
Dividend Yield
2.30%
N/A
EPS Growth
26.83
28.28
EPS
1.47
N/A
Revenue
N/A
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.48
N/A
Revenue Growth
N/A
43.96
52 Week Low
$16.03
$1.12
52 Week High
$20.00
$3.96

Technical Indicators

Market Signals
Indicator
MGYR
RFL
Relative Strength Index (RSI) 57.28 37.69
Support Level $16.95 $1.86
Resistance Level $19.89 $2.16
Average True Range (ATR) 0.39 0.22
MACD -0.03 -0.05
Stochastic Oscillator 98.72 0.00

Price Performance

Historical Comparison
MGYR
RFL

About MGYR Magyar Bancorp Inc.

Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: